John D. Gerace
President, DiaSorin Molecular LLC
John Gerace is currently President of DiaSorin Molecular.
He receives Bachelors of Science degrees in chemistry and biological sciences from the University of California, Irvine and a MBA from Pepperdine University.
Early in his career, Mr. Gerace spends 15 years at Beckman Coulter where he holds various leadership roles in Sales, Marketing and Business Development.
He co-founds Calabri Biosciences – a biosensor / digital health technologies investment portfolio.
He is CEO of Freedom Meditech – a company commercializing non-invasive disease detection and monitoring products. He stages and sells the company to Sinocare, Inc. in China.
From 2007 to 2014, Mr. Gerace serves as the Vice President and General Manager of PCR Systems and then as Head of Applied Markets at Life Technologies.
In 2016 he is appointed President of DiaSorin Molecular LLC.
He is a Trustee at the Iacocca Family Foundation - with the objective of accelerating the discovery of a cure for Type-1 Diabetes. He also serves as a Trustee of the UC Irvine Foundation.